Sponsor:
Seda S. Tolu
Code:
NCT07283822
Conditions
Non-Hodgkin Lymphoma
Hodgkin Disease Lymphoma
Non-Hodgkin Lymphoma Refractory/ Relapsed
Hodgkin Disease Recurrent
Gray Zone Lymphoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ruxolitinib
Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-26. This information was provided to ClinicalTrials.gov by Seda S. Tolu on 2025-12-16.